Neuro-protective effects of growth hormone (GH) after hypoxia-ischemia injury in embryonic chicken cerebellum

General and Comparative Endocrinology

Volumn 183, Issue , 2013, Pages 17-31

  Alba Betancourt, Clara ^a   Luna Acosta, José Luis ^a   Ramírez Martínez, Candy Elizabeth ^a   Ávila González, Daniela ^a   Granados ávalos, Estefany ^a   Carranza, Martha ^a   Martínez Coria, Hilda ^b   Arámburo, Carlos ^a   Luna, Maricela ^a  

^a INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti apoptotic effects; Growth hormone (GH); Hypoxia and low glucose (HLG); Neuroprotection; PI3K Akt; Wortmannin

Indexed keywords

CASPASE 3; GLUCOSE; GROWTH HORMONE; HYPOXIA LOW GLUCOSE; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; RECOMBINANT GROWTH HORMONE; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CELL CULTURE; CELL VIABILITY; CEREBELLUM; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERODIAGNOSIS; SIGNAL TRANSDUCTION;

EID: 84871986878     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2012.12.004     Document Type: Article

References (93)

1. Alba-Betancourt C., ávila-Mendoza J., Ahumada-Solórzano S.M., Rodríguez-Méndez A.J., Carranza M., Harvey S., Arámburo C., Luna M. Expression, cellular distribution, and heterogeneity of growth hormone in the chicken cerebellum during development. Gen. Comp. Endocrinol. 2011, 170:528-540.
2. Arámburo C., Sáchez-García R., Fenton-Navarro B., Perera-Marín J.G., Valverde-Rodríguez C. Desarrollo de un radioinmunoensayo homólogo y específico para la determinación de hormona del crecimiento de pollo (cGH). Veterinaria México 1989, 20:397-405.
3. Arámburo C., Navarrete S., Montiel J.L., Sánchez R., Berghman L.R. Purification and electrophoretic analysis of glycosylated chicken growth hormone (G-cGH): evidence of G-cGH isoforms. Gen. Comp. Endocrinol. 1991, 84:135-146.
4. Arámburo C., Luna M., Carranza M., Reyes M., Martínez-Coria H., Scanes C.G. Growth hormone size variants: changes in the pituitary during development of the chicken. Proc. Soc. Exp. Biol. Med. 2000, 223:67-74.
5. Arámburo C., Carranza M., Reyes M., Luna M., Martínez-Coria H., Berúmen L., Scanes C.G. Characterization of a bioactive 15kDa fragment produced by proteolytic cleavage of chicken growth hormone. Endocrine 2001, 15:231-240.
6. Baker N.L., Carlo Russo V., Bernard O., D'Ercole A.J., Werther G.A. Interactions between bcl-2 and the IGF-I system control apoptosis in the developing mouse brain. Brain Res. Dev. Brain Res. 1999, 118:109-118.
7. Baudet M.L., Sanders E.J., Harvey S. Retinal growth hormone in the chick embryo. Endocrinology 2003, 144:5459-5468.
8. Beilharz E.J., Williams C.E., Dragunow M., Sirimanne E.S., Gluckman P.D. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Mol. Brain Res. 1995, 29:1-14.
9. Bonfoco E., Krainc D., Ankarchona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 1995, 92:162-166.
10. Bossenmeyer C., Chihab R., Muller S., Schroeder H., Daval J.L. Hypoxia/reoxygenation induces apoptosis through biphasic induction of protein synthesis in central neurons. Brain Res. 1998, 787:107-116.
11. Brewer G.J., Torricelli J.R., Evege E.K., Price P.J. Neurobasal 1% Medium/B27 supplement: a new serum-free medium combination for survival of neurons. Focus 1994, 16:6-9.
12. Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995, 376:599-602.
13. Burton K.A., Kabigting E.B., Clifton D.K., Steiner R. Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat and its colocalization in hypothalamic somatostatin neurons. Endocrinology 1992, 130:958-963.
14. Camm E.J., Gibbs M.E., Harding R., Mulder T., Rees S.M. Prenatal hypoxia impairs memory function but does not result in overt structural alterations in the postnatal chick brain. Dev. Brain Res. 2005, 160:9-18.
15. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998, 282:1318-1321.
16. Chung H., Kim E., Lee D.H., Seo S., Ju S., Lee D., Kim H., Park S. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 2007, 148:148-159.
17. Clark R.S., Chen J., Watkins S.C., Kochanek P.M., Chen M., Stetler R.A., Loeffert J.E., Graham S.H. Apoptosis suppressor gene bcl-2 expression after traumatic brain injury in rats. J. Neurosci. 1997, 17:9172-9182.
18. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 1997, 326:1-16.
19. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
20. Deijen J.B., Arwert L.I. Cognitive status of adult growth hormone (GH)-deficient patients and GH-induced neuropsychological changes. The Somatotrophic Axis in Brain Function 2006, 287-300. Elsevier Academic Press, San Diego, California, USA. F. Nyberg (Ed.).
21. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997, 278:687-689.
22. Donahue C.P., Jensen R.V., Ochiishi T., Eisenstein I., Zhao M., Shors T., Kosik K.S. Transcriptional profiling reveals regulated genes in the hippocampus during memory formation. Hippocampus 2002, 12:821-833.
23. Ferrer I., Planas A.M. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J. Neuropathol. Exp. Neurol. 2003, 62:329-339.
24. Frago L.M., Pañeda C., Dickson A.L., Hewson A.K., Argente J., Chowen J.A. Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 2002, 143:4113-4122.
25. Franke T.F., Yang S.I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., Kaplan D.R., Tsichlis P.N. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995, 81:727-736.
26. Fuentes-Prior P., Salvesen G.S. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 2004, 384:201-232.
27. Fuh G., Cunningham B.C., Fukunaga R., Nagata S., Goeddel D.V., Wells J.A. Rational design of potent antagonists to the human growth hormone receptor. Science 1992, 256:1677-1680.
28. Gibson M.E., Han B.H., Choi J., Knudson C.M., Korsmeyer S.J., Parsadanian M., Holtzman D.M. BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways. Mol. Med. 2001, 7:644-655.
29. González-Juanatey J.R., Piñeiro R., Iglesias M.J., Gualillo O., Kelly P.A., Diéguez C., Lago F. GH prevents apoptosis in cardiomyocytes cultured in vitro through a calcineurin-dependent mechanism. J. Endocrinol. 2004, 180:325-335.
30. Gustafson K., Hagberg H., Bengtsson B., Brantsing C., Isgaard J. Possible protective role of growth hormone in hypoxia-ischemia in neonatal rats. Pediatr. Res. 1999, 43:318-323.
31. Haeffner A., Déas O., Mollereau B., Estaquier J., Mignon A., Haeffner-Cavaillon N., Charpentier B., Senik A., Hirsch F. Growth hormone prevents human monocytic cells from Fas-mediated apoptosis by up-regulating Bcl-2 expression. Eur. J. Immunol. 1999, 29:334-344.
32. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S.A., Lowe S.W., Penninger J.M., Mak T.W. Differential requirement for caspase-9 in apoptotic pathways in vivo. Cell 1998, 94:339-352.
33. Hallin U., Kondo E., Ozaki Y., Hagberg H., Shibasaki F., Blomgren K. Bcl-2 phosphorylation in the BH4 domain precedes caspase-3 activation and cell death after neonatal cerebral hypoxic-ischemic injury. Neurobiol. Dis. 2006, 21:478-486.
34. Harvey S. Extrapituitary growth hormone. Endocrine 2010, 38:335-359.
35. Harvey S., Johnson C.D., Sharma P., Sanders E.J., Hull K.L. Growth hormone: a paracrine growth factor in embryonic development?. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol. 1998, 119:305-315.
36. Harvey S., Johnson C.D., Sanders E.J. Growth hormone in neural tissues of the chick embryo. J. Endocrinol. 2001, 169:487-498.
37. Harvey S., Hull K. Neural growth hormone. J. Mol. Neurosci. 2003, 20:1-14.
38. Harvey S., Baudet M.L., Murphy A., Luna M., Hull K.L., Arámburo C. Testicular growth hormone (GH): GH expression in spermatogonia and primary spermatocytes. Gen. Comp. Endocrinol. 2004, 139:158-167.
39. Harvey S., Baudet M.L., Sanders E.J. Growth hormone and cell survival in the neural retina: caspase dependence and independence. NeuroReport 2006, 17:1715-1718.
40. Harvey S., Martin B.T., Baudet M.L., Davis P., Sauve Y., Sanders E.J. Growth hormone in the visual system: comparative endocrinology. Gen. Comp. Endocrinol. 2007, 153:124-131.
41. Hojvat S., Baker G., Kirsteins L., Lawrence A.M. Growth hormone (GH) immunoreactivity in the rodent and primate CNS: distribution, characterization and presence post-hypophysectomy. Brain Res. 1982, 239:543-557.
42. Jacobs C.M., Aden P., Mathisen G.H., Khoung E., Gaarder M., Loberg E.M., Lomo J., Maehlen J., Paulsen R.E. Chicken cerebellar granule neurons rapidly develop excitotoxicity in culture. J. Neurosci. Methods 2006, 156:129-135.
43. Jeay S., Sonenshein G.E., Postel-Vinay M.C., Baixeras E. Growth hormone prevents apoptosis through activation of nuclear factor-kB in interleukin-3-dependent Ba/F3 cell line. Mol. Endocrinol. 2000, 14:650-661.
44. Kiess W., Gallaher B. Hormonal control of programmed cell death/apoptosis. Eur. J. Endocrinol. 1998, 138:482-491.
45. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275:1132-1136.
46. Kuida K. Caspase-9. Int. J. Biochem. Cell Biol. 2000, 32:121-124.
47. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
48. Lai Z., Emtner M., Roos P., Nyberg F. Characterization of putative growth hormone receptors in human choroid plexus. Brain Res. 1991, 546:222-226.
49. Li R.C., Guo S.Z., Raccurt M., Moudilou E., Morel G., Brittian K.R., Gozal D. Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats. Neuroscience 2011, 196:237-250.
50. Lobie P.E., Garcia-Aragon J., Lincoln D.T., Barnard R., Wilcox J.N., Walters M.J. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Brain Res. Dev. Brain Res. 1993, 74:225-233.
51. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 2003, 4:399-415.
52. Luna M., Huerta L., Berumen L., Martínez-Coria H., Harvey S., Arámburo C. Growth hormone in the male reproductive tract of the chicken: heterogeneity and changes during ontogeny and maturation. Gen. Comp. Endocrinol. 2004, 137:37-49.
53. Luna M., Barraza N., Berumen L., Carranza M., Pedernera E., Harvey S., Arámburo C. Heterogeneity of growth hormone immunoreactivity in lymphoid tissues and changes during ontogeny in domestic fowl. Gen. Comp. Endocrinol. 2005, 144:28-37.
54. Luna M., Rodríguez-Mendez A.J., Berumen L., Carranza M., Riesgo-Escovar J., Baudet M.L., Harvey S., Arámburo C. Immune growth hormone (GH): localization of GH and GH mRNA in the bursa of Fabricius. Dev. Comp. Immunol. 2008, 32:1313-1325.
55. Lyuh E., Kim H.J., Kim M., Lee J.K., Park K.S., Yoo K.Y., Lee K.W., Ahn Y.O. Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells. Growth Horm. IGF Res. 2007, 17:315-322.
56. Martínez-Coria H., López-Rosales J., Carranza M., Berumen L., Luna M., Arámburo C. Differential secretion of chicken growth hormone variants after GHRH stimulation, in vitro. Endocrine 2002, 17:91-102.
57. Mehta S.L., Manhas N., Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 2007, 54:34-66.
58. Meisel A., Prass K., Wolf T., Dirnagl U. Stroke. Neuroprotection, Models, Mechanisms and Therapies 2004, 1-30. Wiley-VCH, Weinheim, Germany. M. Bähr (Ed.).
59. Mullen R.J., Buck C.R., Smith A.M. NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992, 116:201-211.
60. Mustafa A., Adem A., Roos P., Nyberg F. Sex differences in binding of human growth hormone to rat brain. Neurosci. Res. 1994, 19:93-99.
61. Northington F.J., Ferriero D.M., Flock D.L., Martin L.J. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J. Neurosci. 2001, 21:1931-1938.
62. Nyberg F. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front. Neuroendocrinol. 2000, 21:330-348.
63. Palmetshofer A., Zechner D., Luger T.A., Barta A. Splicing variants of the human growth hormone mRNA: detection in pituitary, mononuclear cells and dermal fibroblast. Mol. Cell. Endocrinol. 1995, 113:225-234.
64. Ramesh R., Kuenzel W.J., Buntin J.D., Proudman J.A. Identification of growth hormone and prolactin containing neurons within the avian brain. Cell Tissue Res. 2000, 299:371-383.
65. Render C.L., Hull K.L., Harvey S. Neural expression of the pituitary GH gene. J. Endocrinol. 1995, 147:413-422.
66. Rodríguez-Méndez A.J., Luna-Acosta J.L., Carranza M., Harvey S., Arámburo C., Luna M. Growth hormone expression in stromal and non-stromal cells in the bursa of Fabricius during bursal development and involution: causal relationships?. Gen. Comp. Endocrinol. 2010, 167:297-307.
67. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C.J., Roger V., Rumsfeld J., Sorlie P., Steinberger J., Thom T., Wasserthiel-Smoller S., Hong Y. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-e171.
68. Sanders E.J., Harvey S. Growth hormone as an early embryonic growth and differentiation factor. Anat. Embryol. 2004, 209:1-9.
69. Sanders E.J., Parker E., Arámburo C., Harvey S. Retinal growth hormone is an anti-apoptotic factor in embryonic retinal ganglion cell differentiation. Exp. Eye Res. 2005, 81:551-560.
70. Sanders E.J., Parker E., Harvey S. Retinal ganglion cell survival in development: mechanisms of retinal growth hormone action. Exp. Eye Res. 2006, 83:1205-1214.
71. Sanders E.J., Parker E., Harvey S. Growth hormone-mediated survival of embryonic retinal ganglion cells: signaling mechanisms. Gen. Comp. Endocrinol. 2008, 156:613-621.
72. Sanders E.J., Baudet M.L., Parker E., Harvey S. Signalling mechanisms mediating local GH action in the neural retina of the chick embryo. Gen. Comp. Endocrinol. 2009, 163:63-69.
73. Scheepens A., Sirimanne E., Beilharz E., Breier B.H., Waters M.J., Gluckman P.D., Williams C.E. Alterations in the neural growth hormone axis following hypoxic-ischemic brain injury. Brain Res. Mol. Brain Res. 1999, 68:88-100.
74. Scheepens A., Williams C.E., Breier B.H., Guan J., Gluckman P.D. A role for the somatotropic axis in neural development, injury and disease. J. Pediatr. Endocrinol. Metab. 2000, 13:1483-1491.
75. Scheepens A., Sirimanne E.S., Breier B.H., Clark R.G., Gluckman P.D., Williams C.E. Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience 2001, 104:677-687.
76. Scheepens A., Moderscheim T.A., Gluckman P.D. The role of growth hormone in neural development. Horm. Res. 2005, 64:66-72.
77. Segard H.B., Moulin S., Boumard S., Augier de Crémiers C., Kelly P.A., Finidori J. Autocrine growth hormone production prevents apoptosis and inhibits differentiation in C2C12 myoblasts. Cell. Signal. 2003, 15:615-623.
78. Shin D.H., Lee E., Kim J.W., Kwon B.S., Jung M.K., Jee Y.H., Kim J., Bae S., Chang Y.P. Protective effect of growth hormone on neuronal apoptosis after hypoxia-ischemia in the neonatal rat brain. Neurosci. Lett. 2004, 354:64-68.
79. Sirotkin A.V., Makarevich A.V. GH regulates secretory activity and apoptosis in cultured bovine granulosa cells through the activation of the cAMP/protein kinase A system. J. Endocrinol. 1999, 163:317-327.
80. Sugawara T., Fujimura M., Morita-Fujimura Y., Kawase M., Chan P.H. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J. Neurosci. 1999, 19:1-6.
81. Sugawara T., Fujimura M., Noshita N., Kim G.W., Saito A., Hayashi T., Narasimhan P., Maier C.M., Chan P.H. Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 2004, 1:17-25.
82. Takeda A., Onodera H., Sugimoto A., Kogui K., Obinata M., Shibahara S. Coordinated expression of messenger RNAs for nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the rat hippocampus following transient forebrain ischemia. Neuroscience 1993, 55:23-31.
83. Tamatani M., Ogawa S., Nuñez G., Tokyama M. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide. Cell Death Differ. 1998, 5:911-919.
84. Tennant J.R. Evaluation of the trypan blue technique for determination of cell viability. Transplantation 1964, 2:685-694.
85. Vannucci R. Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr. Res. 1990, 27:317-326.
86. Volpe J.J. Cerebellum of the premature infant: rapidly developing, vulnerable, clinically important. J. Child Neurol. 2009, 24:1085-1104.
87. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. BAD, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995, 80:285-291.
88. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275:1129-1132.
89. Yoshizato H., Fujikawa T., Soya H., Tanaka M., Nakashima K. The growth hormone (GH) gene is expressed in the lateral hypothalamus: enhancement by GH-releasing hormone and repression by restraint stress. Endocrinology 1998, 139:2545-2551.
90. Yoshizato H., Fujikawa T., Shibata M., Tanaka M., Nakashima K. Stimulation of growth hormone gene expression in the pituitary and brain by Panax ginseng C. A. Meyer. Endocr. J. 1999, 46:85-88.
91. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996, 87:619-628.
92. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997, 90:405-413.
93. Zou H., Li Y., Liu X., Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 1999, 274:11549-11556.